Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
TELEFLEX INC
Teleflex Inc insider Sean Salmon filed a Form 4 report regarding changes in beneficial ownership of securities dated September 8, 2026. This filing represents a routine disclosure of insider stock activity and does not involve any material financial changes or new share issuances.…more
TELEFLEX INC
Teleflex Inc. filed a Form 4 on May 14, 2024, reporting that Director Sean Salmon acquired 1,000 shares of the company's common stock. Following this transaction, Director Salmon's total beneficial ownership stands at 1,000 shares.…more
TELEFLEX INC
Janus Henderson Group Ltd. has filed a Power of Attorney appointing Kristin Mariani and Caroline Barotti as attorneys-in-fact to handle SEC reporting requirements for the company and its affiliates. This filing clarifies the reporting authority for securities held by various asset managers under the Janus Henderson umbrella.…more
7 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
Teleflex Receives FDA Breakthrough Device Designation For Freesolve
Teleflex's Freesolve resorbable magnesium scaffold has been granted FDA Breakthrough Device Designation. The device has demonstrated positive long-term clinical outcomes and offers a potential alternative for percutaneous coronary intervention.…more
●●●●●●●● ●●●●● ●●●●●●
Teleflex has successfully completed patient enrollment for its BIOMAG-LL clinical study evaluating the Freesolve Resorbable Magnesium Scaffold. The study aims to assess the safety and clinical performance of the device in treating long coronary lesions.…more
1 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.